5934-50-9 Usage
General Description
Hyoscyamine hydrochloride is a medication that belongs to the class of drugs known as anticholinergics. It is derived from the plant Hyoscyamus niger and is used to treat a variety of gastrointestinal disorders, including irritable bowel syndrome, diverticulitis, and peptic ulcer disease. Hyoscyamine hydrochloride works by blocking the action of acetylcholine, a neurotransmitter that controls smooth muscle contractions in the stomach and intestines, leading to relaxation of the muscles and a decrease in gastrointestinal motility. This helps to relieve symptoms such as abdominal pain, cramping, and bloating. It is available in various forms, including tablets, capsules, and oral solution, and is typically taken multiple times a day as directed by a healthcare professional. Common side effects of hyoscyamine hydrochloride may include dry mouth, blurred vision, dizziness, and constipation.
Check Digit Verification of cas no
The CAS Registry Mumber 5934-50-9 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 5,9,3 and 4 respectively; the second part has 2 digits, 5 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 5934-50:
(6*5)+(5*9)+(4*3)+(3*4)+(2*5)+(1*0)=109
109 % 10 = 9
So 5934-50-9 is a valid CAS Registry Number.
InChI:InChI=1/C17H23NO3.ClH/c1-18-13-7-8-14(18)10-15(9-13)21-17(20)16(11-19)12-5-3-2-4-6-12;/h2-6,13-16,19H,7-11H2,1H3;1H/t13?,14?,15?,16-;/m1./s1
5934-50-9Relevant articles and documents
Stereochemistry of the 1,2-migration of the carboxyl group that occurs during the biosynthesis of tropic acid from phenylalanine
Leete, Edward
, p. 226 - 228 (2007/10/02)
(2S,3R)- and (2S,3S)-phenylalanine were fed in separate experiments to Datura innoxia plants.The distribution of isotopes in the resultant labeled hyoscyamine and scopolamine indicates that the biosynthesis of the acid moiety of these ester alkaloids, namely (S)-tropic acid, involves the migration of the carboxyl group of phenylalanine to its prochiral C-3 position with retention of configuration.
